Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
LCI Industries | LCII | 17. jan 2025 | 107.28 | -0.46 |
LCNB | LCNB | 17. jan 2025 | 15.07 | 0.00 |
Lead Real Estate ADR | LRE | 17. jan 2025 | 1.76 | -1.49 |
Leafly | LFLY | 17. jan 2025 | 1.44 | 0.00 |
Leap Therapeutics | LPTX | 17. jan 2025 | 2.55 | -1.16 |
Lear | LEA | 17. jan 2025 | 94.32 | +0.15 |
LeddarTech | LDTC | 17. jan 2025 | 1.17 | 0.00 |
Lee Enterprises | LEE | 17. jan 2025 | 12.15 | -3.34 |
Legacy Housing | LEGH | 17. jan 2025 | 25.06 | +2.27 |
LegalZoom.com | LZ | 17. jan 2025 | 8.20 | +0.37 |
Legato Merger III | LEGT | 17. jan 2025 | 10.31 | +0.10 |
Legend Biotech ADR | LEGN | 17. jan 2025 | 32.66 | +3.91 |
Legg Mason Low Volatility High Dividend ETF | LVHD | 17. jan 2025 | 38.84 | +0.44 |
Leggett & Platt | LEG | 17. jan 2025 | 10.64 | -1.21 |
Leidos | LDOS | 17. jan 2025 | 155.18 | +0.06 |
Leishen Energy Holding Co | LSE | 17. jan 2025 | 7.39 | 0.00 |
LeMaitre Vascular | LMAT | 17. jan 2025 | 99.06 | +0.85 |
Lemonade | LMND | 17. jan 2025 | 32.83 | -0.52 |
LendingClub | LC | 17. jan 2025 | 16.65 | +1.96 |
LendingTree | TREE | 17. jan 2025 | 40.64 | +0.87 |
Lendway | LDWY | 17. jan 2025 | 4.60 | -1.08 |
Lennar A | LEN | 17. jan 2025 | 141.54 | +0.60 |
Lennar B | LEN-B | 17. jan 2025 | 135.52 | +0.51 |
Lennox International | LII | 17. jan 2025 | 647.46 | +0.72 |
LENSAR | LNSR | 17. jan 2025 | 8.32 | -2.92 |
LENZ Therapeutics | LENZ | 17. jan 2025 | 22.50 | +0.45 |
Leonardo DRS | DRS | 17. jan 2025 | 35.61 | +2.18 |
Lesaka Technologies | LSAK | 17. jan 2025 | 5.28 | +3.07 |
Leslies | LESL | 17. jan 2025 | 2.16 | -3.14 |
Levi Strauss & Co A | LEVI | 17. jan 2025 | 17.37 | -1.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.